Latest news with #HidemaruYamaguchi
Business Insider
29-06-2025
- Business
- Business Insider
Citi Reaffirms Their Hold Rating on Medipal Holdings (MEPDF)
In a report released on June 26, Hidemaru Yamaguchi from Citi maintained a Hold rating on Medipal Holdings (MEPDF – Research Report), with a price target of Yen2,410.00. The company's shares closed last Friday at $16.25. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Yamaguchi is an analyst with an average return of -2.6% and a 37.50% success rate. Yamaguchi covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Chugai Pharmaceutical Co, and Sumitomo Dainippon Pharma Co. The word on The Street in general, suggests a Hold analyst consensus rating for Medipal Holdings with a $17.21 average price target.
Business Insider
28-06-2025
- Business
- Business Insider
Citi Reaffirms Their Sell Rating on Sumitomo Dainippon Pharma Co (DNPUF)
In a report released yesterday, Hidemaru Yamaguchi from Citi maintained a Sell rating on Sumitomo Dainippon Pharma Co (DNPUF – Research Report), with a price target of Yen800.00. The company's shares closed last Thursday at $6.55. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Yamaguchi covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Chugai Pharmaceutical Co, and Sumitomo Dainippon Pharma Co. According to TipRanks, Yamaguchi has an average return of -2.6% and a 37.50% success rate on recommended stocks. Sumitomo Dainippon Pharma Co has an analyst consensus of Moderate Buy, with a price target consensus of $6.24. The company has a one-year high of $7.12 and a one-year low of $2.19. Currently, Sumitomo Dainippon Pharma Co has an average volume of 212.
